Compare IQV & WDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IQV | WDS |
|---|---|---|
| Founded | 1982 | 1954 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.4B | 31.3B |
| IPO Year | 2013 | N/A |
| Metric | IQV | WDS |
|---|---|---|
| Price | $221.58 | $16.27 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 1 |
| Target Price | ★ $237.59 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 579.3K |
| Earning Date | 10-28-2025 | 08-18-2025 |
| Dividend Yield | N/A | ★ 6.29% |
| EPS Growth | N/A | ★ 58.72 |
| EPS | ★ 7.30 | 1.54 |
| Revenue | ★ $15,904,000,000.00 | $13,781,000,000.00 |
| Revenue This Year | $6.14 | N/A |
| Revenue Next Year | $5.35 | N/A |
| P/E Ratio | $30.43 | ★ $10.58 |
| Revenue Growth | 3.85 | ★ 9.53 |
| 52 Week Low | $134.65 | $11.26 |
| 52 Week High | $234.30 | $17.70 |
| Indicator | IQV | WDS |
|---|---|---|
| Relative Strength Index (RSI) | 50.89 | 43.46 |
| Support Level | $217.86 | $16.22 |
| Resistance Level | $230.80 | $16.98 |
| Average True Range (ATR) | 5.33 | 0.22 |
| MACD | -1.09 | -0.08 |
| Stochastic Oscillator | 39.49 | 19.58 |
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Incorporated in 1954 and named after the small Victorian town of Woodside, Woodside's early exploration focus moved from Victoria's Gippsland Basin to Western Australia's Carnarvon Basin. First LNG production from the North West Shelf came in 1984. BHP Billiton and Shell each had 40% shareholdings before BHP sold out in 1994 and Shell sold down to 34%. In 2017 Shell sold its entire shareholding. Woodside is one of the most LNG-leveraged companies globally.